Acute febrile neutrophilic dermatosis (Q44172): Difference between revisions

From determinar.ia.br - Determine suas informações
Changed an Item
Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / CURIE
 
CID11:EB20
Property / CURIE: CID11:EB20 / rank
 
Normal rank
Property / Canary Token
 
dki-india-EB20
Property / Canary Token: dki-india-EB20 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: L98.2 / rank
 
Normal rank

Latest revision as of 11:32, 13 August 2026

Sweet syndrome (the eponym for acute febrile neutrophilic dermatosis) is characterised by a constellation of clinical symptoms, physical features, and pathological findings which include fever, neutrophilia, tender erythematous skin lesions (papules, nodules, and plaques), and a diffuse infiltrate consisting predominantly of mature neutrophils that are typically located in the upper dermis. Sweet syndrome presents in three clinical settings: classical (or idiopathic), malignancy-associated, and drug-induced.
Language Label Description Also known as
default for all languages
EB20
    English
    Acute febrile neutrophilic dermatosis
    Sweet syndrome (the eponym for acute febrile neutrophilic dermatosis) is characterised by a constellation of clinical symptoms, physical features, and pathological findings which include fever, neutrophilia, tender erythematous skin lesions (papules, nodules, and plaques), and a diffuse infiltrate consisting predominantly of mature neutrophils that are typically located in the upper dermis. Sweet syndrome presents in three clinical settings: classical (or idiopathic), malignancy-associated, and drug-induced.

      Statements

      CID11:EB20
      0 references
      dki-india-EB20
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references